尼妥珠单抗生物仿制药具有人源化人-小鼠h-R3重链和人源化人-小鼠h-R3κ链。尼妥珠单抗与表皮生长因子受体（EGFR）结合，表皮生长因子受体是一种通常控制细胞分裂的信号蛋白。 尼妥珠单抗生物仿制药-研究级该产品同种型对照：Bulk Human IgG1 Isotype Control (IB1) [ICH2254] 缓冲液：ICH3001-100ml，nICH3002-100ml，nICH3003-100ml， 浓度：1.0 - 5.0 mg/ml 纯度：>95% by SDS-PAGE and HPLC 内毒素：≤ 1.0 EU/mg as determined by the LAL method 制剂：Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.
